Company
Merit Medical Systems
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
76
510(k), De Novo and PMA
Device trials
26
As lead sponsor, any status
Adverse event reports
969
Received Nov 1, 2025 to Nov 20, 2026
Recall records
301
One per recalled product
Merit Medical Systems is on our public-company list (ticker MMSI). Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
MMSI
Nasdaq · MERIT MEDICAL SYSTEMS INC
Public float
$5.40B
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$1.52B
Fiscal year ending Dec 31, 2025
Net income
$128M
Fiscal year ending Dec 31, 2025
R&D spending
$97.4M
Fiscal year ending Dec 31, 2025
Cash
$504M
As of Sep 30, 2026
Long-term debt
$737M
As of Sep 30, 2026
Shares outstanding
59.9M
As of Oct 27, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2025 | – | $28.2M | – | – |
| 2024 | – | $40.9M | – | – |
| 2023 | – | $15.6M | – | – |
| 2022 | – | $20.1M | $215M | – |
| 2021 | – | $21.3M | $98.4M | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
The 8 newest of 76 since 2015.
K261310 · Decided Jul 27, 2026 · 97 days after receipt
Device type: Dilator, Vessel, For Percutaneous Catheterization (DRE) · Cardiology
75 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT05818150 · 52 participants · Start Jan 16, 2024 · Primary completion May 28, 2026
Device: Embosphere Microspheres · For: Knee Osteoarthritis
Sites: Washington D.C., District of Columbia; Atlanta, Georgia; Chicago, Illinois · 17 sites in all
25 more trials with a free account
Reports received
969
Received Nov 1, 2025 to Nov 20, 2026. Includes 3 of another or unstated type.
Malfunction reports
647
67% of reports
Injury reports
309
32% of reports
Death reports
10
1.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 4 | 7 | 0 | 0 |
| Jan 24 | 13 | 9 | 0 | 0 |
| Feb 24 | 14 | 9 | 0 | 0 |
| Mar 24 | 9 | 10 | 0 | 0 |
| Apr 24 | 11 | 8 | 0 | 0 |
| May 24 | 8 | 6 | 1 | 0 |
| Jun 24 | 15 | 6 | 0 | 0 |
| Jul 24 | 19 | 14 | 0 | 0 |
| Aug 24 | 11 | 15 | 3 | 0 |
| Sep 24 | 15 | 16 | 2 | 0 |
| Oct 24 | 7 | 12 | 0 | 0 |
| Nov 24 | 11 | 13 | 0 | 0 |
| Dec 24 | 21 | 9 | 1 | 0 |
| Jan 25 | 13 | 10 | 0 | 0 |
| Feb 25 | 9 | 16 | 1 | 0 |
| Mar 25 | 29 | 13 | 2 | 0 |
| Apr 25 | 25 | 26 | 0 | 0 |
| May 25 | 45 | 45 | 0 | 0 |
| Jun 25 | 40 | 15 | 0 | 0 |
| Jul 25 | 69 | 39 | 1 | 0 |
| Aug 25 | 84 | 23 | 0 | 0 |
| Sep 25 | 29 | 5 | 1 | 0 |
| Oct 25 | 40 | 9 | 0 | 0 |
| Nov 25 | 69 | 12 | 2 | 0 |
| Dec 25 | 66 | 13 | 2 | 0 |
| Jan 26 | 36 | 7 | 1 | 0 |
| Feb 26 | 25 | 2 | 0 | 0 |
| Mar 26 | 99 | 37 | 0 | 0 |
| Apr 26 | 58 | 28 | 1 | 0 |
| May 26 | 56 | 22 | 1 | 0 |
| Jun 26 | 70 | 43 | 0 | 0 |
| Jul 26 | 81 | 68 | 2 | 0 |
| Aug 26 | 38 | 34 | 0 | 3 |
| Sep 26 | 29 | 24 | 1 | 0 |
| Oct 26 | 20 | 19 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- ACHIEVE®85
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0187-2027 · Started Aug 27, 2026 · Posted by FDA Oct 15, 2026
Reason given: The implantable clip may experience difficulties deploying, which could prevent the reflector from functioning as intended during use.
Cause as FDA categorized it: Process control · Device type: Marker, Radiographic, Implantable (NEU)
300 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.